申请人:Children's Hospital Medical Center
公开号:US10857211B2
公开(公告)日:2020-12-08
Markers for genomic instability in Fanconi Anemia (FA) and other pathologies for therapeutic and diagnostic uses. In one embodiment, glycosphingolipid metabolism is altered in the FA deficient squamous cell carcinoma (SCC) cells, based on analysis of a metabolomics/lipidomics platform. The data indicated ganglioside metabolism was important in FA patients' susceptibility to SCC progression.
用于治疗和诊断的范可尼贫血症(FA)和其他病症基因组不稳定性的标记物。在一个实施方案中,根据代谢组学/脂质组学平台的分析,FA 缺陷鳞状细胞癌(SCC)细胞中的糖磷脂代谢发生了改变。数据表明,神经节苷脂代谢在 FA 患者易患 SCC 的过程中起着重要作用。